1,9-bridged thiazolo[3,2-a]quinoline derivatives

US5618815A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Thomas Jaetsch · Cologne, DE
• Werner Hallenbach · Nordhorn, DE
• Thomas Himmler · Odenthal, DE
• Burkhard Mielke · Leverkusen, DE
• Klaus-Dieter Bremm · Recklinghausen, DE
• Rainer Endermann · Wuppertal, DE
• Franz Pirro · Langenfeld, DE
• Michael Stegemann · Lenexa, US
• Heinz-Georg Wetzstein · Leverkusen, DE

Key dates

• Filing date: May 19, 1995
• Grant date: Apr 8, 1997
• Expiry date: May 19, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to 1,9-bridged thiazolo[3,2-a]quinoline derivatives of the general formula (I) ##STR1## in which the substituents Z, X, R.sup.1 have the meaning given in the description, to processes for their preparation and to their use in antibacterial compositions.